Summary. Antimicrobial resistance among 199 1 Pseudomonas aeruginosa isolates collected at 24 UK hospitals during late 1993 was surveyed. Three-hundred and seventy-two of the isolates were resistant, or had reduced susceptibility, to some or all of azlocillin, carbenicillin, ceftazidime, imipenem and meropenem, and the mechanisms underlying their behaviour were examined. Only 13 isolates produced secondary p-lactamases : six possessed PSE-1 or PSE-4 enzymes and seven had novel OXA enzyme types. Those with PSE types were highly resistant to azlocillin and carbenicillin whereas those with OXA enzymes were less resistant to these penicillins. Chromosomal p-lactamase derepression was demonstrated in 54 isolates, most of which were resistant to ceftazidime and azlocillin although susceptible to carbenicillin and carbapenems. p-Lactamase-independent " intrinsic" resistance occurred in 277 isolates and is believed to reflect some combination of impermeability and efflux. Two forms were seen : the classical type, present in 195 isolates, gave carbenicillin resistance (MIC > 128 mg/L) and reduced susceptibility to ciprofloxacin and to all p-lactam agents except imipenem; a novel variant, seen in 82 isolates, affected only azlocillin, ceftazidime and, to a small extent, meropenem. Resistance to imipenem was largely dissociated from that to other p-lactam agents, and probably reflected loss of D2 porin, whereas resistance to meropenem was mostly associated with intrinsic resistance to penicillins and cephalosporins. Comparison of the present results with those of a similar study in 1982 revealed significant increases in the proportions of isolates with intrinsic resistance or stable derepression (p < 0.01, x2 test).
Introduction
Most Pseudornonas aeruginosa isolates are susceptible to ureido-and carboxy-penicillins, ceftazidime, cefoperazone, cefsulodin, aztreonam, imipenem and meropenem. Nevertheless, resistance to these agents can arise by various mechanisms, including mutational derepression of the AmpC chromosomal plactamase,l, ' acquisition of secondary plasmid-or transposon-mediated p-lactama~es,~,~ reduced permeability5. or multi-drug efflux'' ' (see Discussion) or, finally, in the case of imipenem, via loss of the D2 porin.', lo During 1993 the incidence of antibiotic resistance amongst P. aeruginosa isolates in the UK was surveyed." Microbiology laboratories in each of 24 Received 
Materials and methods

Selection of isolates
Of the 1991 P. aeruginosa isolates collected in the 1993 survey," 372 were examined, being selected because they were resistant to one or more of the following drug concentrations: azlocillin 16 mg/L; carbenicillin 128 mg/L; ceftazidime 4 mg/L; imipenem 4 mg/L, meropenem 4 mg/L. These concentrations were selected to facilitate discrimination of normal isolates from those with abnormally reduced susceptibility, and do not invariably coincide with clinical breakpoints." The MIC tests allowing this categorisation were performed on IsoSensitest Agar (Chipath) with inocula of lo4 cfufspot, and have been described already." Reference P. aeruginosa strains included NCTC10662, as the control in the susceptibility testing, R20, as a control with known inducibility of AmpC P-lactamase,13 and 1405-con and 2297-con, with derepressed AmpC p-lactamase expre~sion.'~ Transconjugants of P. aeruginosa PU2 1 and Escherichia coli K-12 553 and J622114 served as sources of reference plasmid-and transposonmediated enzymes.
An timicrobial agents
Antimicrobial agents were from suppliers as follows : azlocillin sodium and ciprofloxacin, Bayer, Newbury, Berkshire ; ampicillin sodium, carbenicillin disodium, clavulanate lithium and cloxacillin sodium, SmithKline Beecham, Brockham Park, Surrey; cephaloridine and oxacillin, Sigma ; cefoxitin and imipenem, Merck, Hoddesdon, Hertfordshire ; ceftazidime, Glaxo, Greenford, Middlesex ; meropenem, Zeneca, Macclesfield, Cheshire; and nitrocefin, BBL, Cockeysville, MD, USA.
/3-Lac tamase de tee tion and typing
Cultures were grown overnight on nutrient agar plates at 37"C, then harvested by washing into 1.5-ml volumes of 0.1 M phosphate buffer, pH 7.0. The washings were transferred to Eppendorf tubes and sonicated for 2 x 30 s at an amplitude of 12 pm, with intermediate cooling on ice. Three 25-pl samples of each sonicate were transferred to wells in a microtitration plate. One well was supplemented with 25 pl of 0.3 mM cloxacillin in 0.1 M phosphate buffer, pH 7.0, one with 25 pl of 0.3 mM clavulanate in 0.1 M phosphate buffer, pH 7.0 and the third with drug-free buffer. After 10 min at room temperature, 25-pl of 0.3 mM nitrocefin in 0.1 M phosphate buffer, pH 7.0, were added to each well. The appearance of a red colour, indicating p-lactamase activity, was noted in comparison to the controls (R20, 1405-con and 2297-con).
Iso-electric focusing of p-lactamases
P-Lactamase extracts were prepared as for the enzyme detection tests described above, except that 0.01 M, rather than 0.1 M, phosphate buffer was used. After centrifugation for 2 min at 12000 (1, the supernates were subjected to electrofocusing at 15 W constant power in polyacrylamide gels (220 x 100 x 1 mm) containing ampholines (Pharmacia, Milton Keynes, Buckinghamshire) 2 % v/v of various pH ranges.15 Enzyme activities were detected by overlaying the gel with 0.5 mM nitrocefin in 0.1 M phosphate buffer, pH 7-0, and observing for the appearance of pink bands. Identification of p-lactamases was by comparison to reference enzymes, run in tracks adjacent to the test samples.
Assays of /I-lactamase actiziity
Cultures were grown overnight at 37°C in 25-ml volumes of nutrient broth with orbital shaking at 150 rpm, then diluted into warm (37°C) 250-ml volumes of the same broth. Incubation was continued for 4 h under the previous conditions. Subsequently, the cells were harvested by centrifugation at 5000y, washed once in 0.1 M phosphate buffer, pH 7.0, resuspended in 8 ml of the same buffer and subjected to two alternate cycles of freezing and thawing. Debris and residual cells were removed by ultracentrifugation for 30 min at 100000 g and 4°C. The supernates were assayed against 0.5 mM p-lactam solutions in 0.1 M phosphate buffer, pH 7.0, by UV spectrophotometry at 37°C. Substrates and wavelengths were : ampicillin, benzylpenicillin and carbenicillin, 23 5 nm ; oxacillin, 265 nm; and cephaloridine, 295 nm.
P-Lactamase induction assays
Sonicates were prepared from logarithmic phase cells in nutrient broth cultures that had or had not been exposed to cefoxitin 500 mg/L for 4 h and were assayed against 0.1 mM nitrocefin in 0.1 mM phosphate buffer, pH 7.0. 
Results
Categorisation of isolates resistant to penicillins or ceftazidime
Nitrocefin tests in the presence and absence of 0.1 mM cloxacillin or clavulanate were performed on 344 isolates selected as resistant to one or more of azlocillin 16 mg/L, carbenicillin 128 mg/ L or ceftazidime 4 mg/L. Most (274), like the p-lactamaseinducible control strain R20, gave a pink colour in the 
Cb, carbenicillin; Az, azlocillin; Caz, ceftazidime; Imp, imipenem ; Mem, meropenem ; PI, iso-electric point; PenG, penicillin G ; Amp, ampicillin; Oxa, oxacillin ; Cld, cephaloridine. *Reference standard. inhibitor-free test only after c. 5-10 min. These reactions were inhibited completely by cloxacillin, but not by clavulanate, and were taken to reflect the chromosomal AmpC p-lactamase, which is universally present in P. aeruginosa and which normally, without induction, is expressed ~e a k l y .~ The remaining 70 resistant isolates gave faster nitrocefin reactions than strain R20; many gave an immediate red colour and all did so within 2-3min. For 57 isolates, and the derepressed control strains 1405-con and 2297-con, these reactions were inhibited by cloxacillin but not by clavulanate; for the other 13 isolates, the reactions were inhibited by clavulanate but not cloxacillin. lactamase(s), as the AmpC type has the converse inhibition profile.3+ l7 Electrofocusing and hydrolysis assays were used to test this inference, and to characterise the j3-lactamases (table I). PSE-1 enzyme was found in five isolates and PSE-4 in one (table I). The other seven isolates had OXA enzymes, as characterised by stronger activity against oxacillin than benzylpenicillin or carbenicillin. Three OXAproducers (isolates 520, 543 and 556) were probably replicates; they were from the same hospital and had the same enzyme. This p-lactamase co-focused with OXA-4, but was relatively more active against ampicillin and less so against oxacillin. The remaining four isolates had unique OXA-type enzymes, none of which co-focused with any previously described type. Electrofocusing revealed two p-lactamase activities (PI 6.8 and 7-67) in one of these isolates (898), and it
Isolates giving strong nitrocefin reactions, inhibited by clavulanate but not cloxacillin
This pattern indicated production of secondary p-remains uncertain whether these were satellite bands
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Isolates with PSE-1 and PSE-4 enzymes were highly resistant to carbenicillin and azlocillin but remained susceptible to both carbapenems and, with one exception (isolate 23 12) , to ceftazidime (table I) . Isolates with OXA enzymes were less resistant to penicillins than those with PSE types. One OW-producer (2241), was resistant to ceftazidime but the others were susceptible to this cephalosporin (table I) .
Isolates giving strong nitrocejn reactions, inhibited by cloxacillin but not clavulanate
This pattern -also observed for the derepressed controls 1405-con and 2297-con -indicated hyperproduction of the AmpC chromosomal P-lactamase, but it might arise via production of another enzyme with similar inhibitor susceptibility. It could also occur trivially, for normal isolates, if nitrocefin tests were over-inoculated. Electrofocusing and specific activity determinations were undertaken to distinguish these possibilities. All 57 isolates had P-lactamases with isoelectric points > 7.5; only the AmpC enzymes have such high iso-electric points and are inhibited by cloxacillin but not clavulanate. Quantitative nitrocefin assays confirmed that 54 of the 57 isolates produced at least five-fold higher uninduced levels of P-lactamase than strain R20, confirming derepression (table 11). The remaining three isolates had uninduced enzyme levels scarcely above that of strain R20 and were transferred to the group of organisms (below) in which resistance was considered to be P-lactamase-independent. In 40 of the 54 isolates, p-lactamase expression remained inducible by cefoxitin, indicating that derepression was only partial. The remaining 14 isolates had the highest p-lactamase specific activities, 9&2900-fold greater than that of strain R20, and were totally derepressed (table 11). Resistance to azlocillin was almost universal amongst the derepressed isolates, with 53 of 54 of them resistant to this penicillin at 16 mg/L and 50 resistant at 32 mg/L. Insusceptibility to ceftazidime was also frequent, with 51 isolates resistant at 4mg/L and 25 isolates resistant to 16 mg/L. Some derepressed isolates were more widely resistant, 25 were insensitive to carbenicillin 128 mg/L, seven insensitive to imipenem 4 mg/L and two insensitive to meropenem 4 mg/L. Generally, however, the level of resistance to carbenicillin and the carbapenems was unrelated to the amount of P-lactamase produced without induction, whereas resistance to azlocillin and ceftazidime was strongly related to enzyme activity (table 11) .
Penicillin-or ceftazidime-resistant isolates that did not give strong nitrocejn reactions
The 274 isolates initially placed in this category were supplemented with the three initially mis-classified as giving strong, cloxacillin-inhibited, nitrocefin reactions (see above). Of the total of 277 isolates, 195 were resistant to carbenicillin at 128 mg/L and had reduced susceptibility, compared to modal MICs, to azlocillin, ceftazidime, meropenem and ciprofloxacin, although not to imipenem ( fig. 1) . This is the typical pattern of "intrinsic resistance" and isolates with this mechanism constituted the upper "tail" of a continuous distribution, not a discrete cluster. This last point is illustrated in fig. 2 , which shows that the MICs of azlocillin, ceftazidime, meropenem and, to some extent, ciprofloxacin were related to those of carbenicillin across the whole spectrum of carbenicillin susceptibility and resistance represented in the survey collection, not just for the 195 isolates in the present group. The remaining 82 isolates in the present group were resistant to one or both of ceftazidime 4 mg/L or azlocillin 16 mg/L and, like isolates with the classical form of intrinsic resistance, had reduced susceptibility to meropenem. They nevertheless remained fully susceptible to carbenicillin and ciprofloxacin, as well as to imipenem ( fig. 1 ).
Isolates resistant to carbapenems
Resistance to carbapenems was considered separately, since imipenem resistance in P. aeruginosa is largely independent of that to penicillins and cephalosporins.1.2v6-Of the 1991 isolates collected in the survey, 59 were resistant to one or both carbapenems at 4 mg/L. Of these, 39 were resistant to imipenem alone, 10 to meropenem alone and 10 to both compounds. Thus, cross-resistance between the two carbapenems was very incomplete. Most (27 of 39) of the isolates resistant to imipenem but not meropenem had modal susceptibility to other plactam agents, except meropenem, to which MICs were raised to 2-4mg/L, as compared to a modal value of 0.5 mg/L. None of these 27 isolates gave a strong nitrocefin reaction. The other 12 isolates in the group had intrinsic resistance (n = 7) or P-lactamase derepression (n = 5) and, consequently, had broader resistances. Of the 20 isolates resistant to meropenem alone or to both carbapenems, 17 had intrinsic resistance to penicillins and cephalosporins, two had stable derepression and one was fully susceptible to every other p-lactam agent. Thus, meropenem resistance, although rarer than imipenem resistance, was much more strongly associated with intrinsic resistance to other P-lactam agents (17 of 20 cf. 7 of 39; p < 0.01, x2 test).
Attempts to determine whether carbapenem-resistant isolates lacked D2 porin, which provides outermembrane pores permeable to carbapenems but not other p-lactam agents, were unsuccessful (not shown), because comparisons to isogenic carbapenem-susceptible parents were not available. mechanisms in relation to patient type. Chromosomal P-lactamase derepression and intrinsic resistance were significantly more frequent amongst isolates from general in-patients than in those from out-patients, whereas imipenem resistance and secondary plactamases were randomly distributed amongst isolates from these groups of patients. Every resistance mechanism appeared commoner in isolates from intensive care unit patients than in those from general inpatients but statistical significance at p < 0-05 was achieved only with respect to imipenem resistance.
Sources of isolates with various modes of resistance
Discussion
Three hundred and seventy-two P. P-Lactamase-mediated resistance remained rare. Secondary P-lactamases were found in only 13 of the 1991 present isolates and in 47 of 1866 collected in 1982. Comparison of these proportions indicates a significant decrease (p < 0.01, x2 test) but few producers were obtained in either year, and analysis was prone to distortion by outbreak strains. In 1982, one hospital contributed 10 indistinguishable isolates with PSE-4 enzyme; another sent 10 with an OXAtype, possibly OXA-6, and three further hospitals sent pairs of likely replicates. In the present study, one hospital sent three isolates (520, 543 and 556: table I) with the same novel OXA enzyme. In this situation it is better to compare the proportions of hospitals sending isolates with secondary p-lactamases ; this declined insignificantly, from 14 of 24 in 1982 to 8 of 24 in 1993 (p > 0.05, x2 test). The scarcity of secondary P-lactamases in P. aeruginosa from the UK is apparent from other s t u d i e~. l ' *~~ Such enzymes are commoner among P. aeruginosa isolates from Francezo and Catalonia,21 occurring in 7-12 % of isolates, but remain much rarer than in enterobacteria, where they are produced by 30-50 70 of isolates.22 Moreover, the predominant enzymes differ amongst bacterial families: PSE-1 and PSE-4 types are commonest in P. aer~ginosa,'~. 20-2 1 , 2 3 as confirmed here, whereas the TEM and SHV types predominate in enterobacteria.22 A scatter of OXA enzymes was found here (table I) intrinsically resistant ( I 5) derepressed (7)
*Does not total 277, as elsewhere, since sources of four intrinsically resistant isolates were unrecorded. tIsolates from non-ICU in-patients were taken as a reference group to which isolates from other patient groups were compared by Fisher's exact tests, with the p values thereby obtained being adjusted by the Bonferroni correction (i.e., doubled in the present cases) to compensate for the fact that two comparisons (one for ICU isolates and one for out-patient isolates) were being made to a single reference group (the in-patient isolates). The groups being compared are indicated by the arrows.
the species. A difference from the 1982 survey was that Isolates with secondary p-lactamases mostly were PSE-1 replaced PSE-4 as the commonest enzyme.
resistant to the penicillins but susceptible to Notably, all the 19 PSE-4 producers collected in 1982 ceftazidime and the carbapenems, reflecting the known were of serogroup 0: I1 and, although from 10 activity of PSE and OXA en~yrnes.~' One isolate with hospitals, most gave similar phage lysis a novel OXA enzyme (2241) was resistant to These findings suggested clonal spread of a resistant ceftazidime (MIC 32 mg/L) but it is doubtful whether strain, which has since disappeared.
the resistance involved the P-lactamase which, when imipenem and Mem, meropenem. Data are analysed with regard to the low breakpoints used elsewhere in this study, and with respect to high breakpoints which may be considered as the limits of clinical susceptibility." It is emphasised that detection of a mechanism does not prove it to be the sole cause of resistance : e.g., although jl-lactamase derepression and intrinsic resistance were present in some imipenem-resistant isolates they do not cause this resistance;'.8 likewise stable derepression does not cause meropenem resistance' and it is doubtful whether the OXA p-lactamase found in one ceftazidime-resistant isolate (2241, see table I) was responsible for that resistance.
extracted, had only feeble activity against 0.5 mM ceftazidime (not shown).
The survey yielded 54 stably derepressed isolates, defined as those with at least five-fold higher uninduced AmpC P-lactamase activity than strain R20. Ureidopenicillins and extended-spectrum cephalosporins, used increasingly since the early 1980s, are labile to AmpC enzymes but are weak inducers of their synthesis, and so select derepressed mutants from inducible pop~lations.l-~ Carboxypenicillins, which were the main antipseudomonal p-lactams before 1980, are more stable and less selective.' Although derepressed organisms remain rare it is telling that most were from in-patients and, especially, those in intensive care units (table 111) . These are the patients in whom antibiotic selection pressure is greatest. The degree of resistance of derepressed organisms to azlocillin and ceftazidime reflected the amount of enzyme produced without induction (table 11) whereas resistance to the more stable agents, carbenicillin, imipenem and meropenem, was not related to enzyme quantity. The largest group of p-lactam-resistant isolates were those lacking untoward p-lactamase activity and with inter-related resistance to penicillins, ceftazidime, ciprofloxacin and meropenem, although not to imipenem ( fig. 1 ). This antibiogram profile is wellknown in P. aeruginosa, and has been termed "intrinsic re~istance".~,',~ Its mechanism was long assumed to be impermeability, because other mechanisms were contra-indicated and because it was difficult to envisage anything else that could compromise such diverse drugs.' However, recent biophysical data suggest increased multi-drug efflux as the mechanism,'~' and a multi-drug efflux operon, cloned from the species, was shown to enhance resistance to quinolones, tetracycline and chl~ramphenicol.~~ Nevertheless, it remains surprising that such a system should affect /I-lactam agents, which have targets external to the cytoplasmic membrane. In the present survey, 195 of 1991 isolates were inferred to have classical intrinsic resistance, with carbenicillin MICs > 128 mg/L and with reduced susceptibility to ceftazidime, azlocillin, meropenem and ciprofloxacin.
